• Home
• Key Data
• Bayer Stock
• Management Report
  • Overview of Sales, Earnings and Financial Position
  • Economic Outlook
  • Sales and Earnings Forecast
  • Corporate Structure
  • Performance by Subgroup, Segment and Region
    • HealthCare
    • CropScience
    • MaterialScience
    • Performance by Region
  • Calculation of EBIT(DA) Before Special Items
  • Core Earnings Per Share
  • Financial Position of the Bayer Group
  • Employees
  • Opportunities and Risks
  • Events After the Reporting Period
• Financial Statements
• Focus
• News
  • Overview
  • Development of higher-yielding sugarcane
  • From waste product to high-quality materials
  • Innovative anti-cancer stem cell therapeutics
  • Natural defense mechanisms for rice
  • New contraceptive pill approved in the United States
  • Contrast agent for MRI in children
  • Research center for functional films in Asia/Pacific
  • New treatment option for erectile dysfunction
  • Supporting the worldwide battle against malaria
  • Improved protection for cotton plants
  • Bayer wins awards for best investor relations activities
  • Sustainability means future viability
  • Multiple sclerosis: follow-up of long-term therapy
  • Aspirin Social Award goes to “Trauerland” children’s project
  • New study in advanced colorectal cancer
• Services
  • Overview
  • Download Center

Print Page

Download Center

Links

Publications

Services

Special Interest

• Investor Relations
• Press
• Jobs and Career
• Foundations
• Culture

• General Conditions of Use
• Privacy Statement
• Imprint
• Technical Details